AA
VXRT

ALPS Advisors’s Vaxart VXRT Stock Holding History

ALPS Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-69,043
Closed -$151K – 1092
2022
Q3 		$151K Sell
69,043
-5,971
-8% -$20.6K ﹤0.01% 1020
2022
Q2 		$263K Buy
+75,014
New +$280K ﹤0.01% 920
2022
Q1 		– Sell
-144,972
Closed -$909K – 979
2021
Q4 		$909K Buy
+144,972
New +$990K 0.01% 373
2021
Q2 		– Sell
-198,053
Closed -$1.2M – 919
2021
Q1 		$1.2M Buy
198,053
+669
+0.3% +$5.15K 0.01% 379
2020
Q4 		$1.13M Buy
+197,384
New +$1.26M 0.01% 377

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ALPS Advisors's VXRT Position: Q4 2022 in Review

ALPS Advisors sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 69,043 shares — an estimated $151K sold.

ALPS Advisors first reported a position in VXRT in Q4 2020 and held it in 5 quarters. The position peaked at $1.2M in Q1 2021. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • ALPS Advisors reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 69,043 Vaxart shares in Q4 2022, an estimated $151K.
  • ALPS Advisors first reported a position in Vaxart in Q4 2020 and held it in 5 quarters.
  • ALPS Advisors's Vaxart position peaked at $1.2M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.